Dr Agarwals Health Care Ltd Gains 6.73%: 3 Key Factors Driving the Surge
2026-11-14 10:00:10Key Events This Week Nov 09: Stock opens at Rs.537.30, surging 4.02% Nov 11: Technical momentum shifts bullish, closing at Rs.554.20 (+3.15%) Nov 13: Hits new 52-week high at Rs.569 and all-time high at Rs.567.55 Nov 13: Week closes at Rs.551.30 (-0.06%) Week OpenRs.516.55 Week CloseRs.551.30</...
Read More
Broad-Based Technical Strength Lifts Dr Agarwals Health Care Ltd to 52-Week High of Rs 569
2026-11-13 12:05:54With a decisive surge to Rs 569 on 13 Nov 2026, Dr Agarwals Health Care Ltd has reached a fresh 52-week high, marking a notable milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained earnings growth, setting the stage for a compelling momentum narrative.
Read More
Dr Agarwals Health Care Ltd is Rated Buy
2026-11-13 10:10:45Dr Agarwals Health Care Ltd is rated Buy by MarketsMOJO, with this rating last updated on 06 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 November 2026, providing investors with the latest insights into its performance and outlook.
Read MoreDr Agarwals Health Care Gains 1.61%: Strong Q2 Performance Drives Weekly Resilience
2026-11-07 10:02:05Key Events This Week Nov 2: Stock opens at Rs.514.15, up 1.14% on strong market sentiment Nov 4: Sharp 2.26% gain to Rs.524.15 following positive trading session Nov 5: Stock dips 2.42% to Rs.511.45 despite Sensex rally Nov 6: Very positive Q2 results announced; stock closes at Rs.516.55 (+1.00%) on heavy volume Week OpenRs.508.35 <div class="stat...
Read More
Dr Agarwals Health Care Ltd Reports Very Positive Q2 2026 Financial Performance
2026-11-06 11:01:23Dr Agarwals Health Care Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, with key metrics reaching record highs. The company’s financial trend has shifted from positive to very positive, reflecting robust revenue growth, margin expansion, and enhanced profitability amid a challenging hospital sector environment.
Read More
Dr Agarwals Health Care Ltd is Rated Hold by MarketsMOJO
2026-11-02 10:10:50Dr Agarwals Health Care Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read More
Dr Agarwals Health Care Ltd Shows Mildly Bullish Momentum Amid Mixed Technical Signals
2026-10-30 08:02:49Dr Agarwals Health Care Ltd, a small-cap player in the hospital sector, has experienced a notable shift in price momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key technical indicators such as MACD, RSI, and moving averages, the stock’s recent 3.34% day gain and a 4.35% weekly return outperforming the Sensex highlight renewed investor interest amid a challenging broader market backdrop.
Read More
Dr Agarwals Health Care Ltd Technical Momentum Shifts Amid Sideways Trend
2026-10-29 08:03:19Dr Agarwals Health Care Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Recent technical indicators including MACD, RSI, Bollinger Bands, and moving averages reveal a nuanced picture of the stock’s price action and momentum, signalling a period of consolidation after recent volatility.
Read MoreAnnouncement under Regulation 30 (LODR)-Allotment
19-Nov-2026 | Source : BSEAllotment of 15190373 Equity Shares of Dr. Agarwals Health Care Limited pursuant to the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and their respective shareholders and creditors ("Scheme")
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
16-Nov-2026 | Source : BSEExecution of Media Agreement by the Company with GoodEdge Advisory Private Limited.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
11-Nov-2026 | Source : BSETranscript of the Discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter and half year ended September 30 2026 at the analyst call held on November 05 2026 is submitted.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
